乐普生物-B盘中涨近7% 此前与ArriVent就MRG007订立独家许可协议

新浪港股
Feb 07, 2025
热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易
客户端

  乐普生物-B(02157)早盘一度涨近7%,截至发稿,股价上涨4.35%,现报2.88港元,成交额1535.12万港元。

  消息面上,乐普生物此前公告称,1月22日,公司与ArriVent Biopharma, Inc.订立独家许可协议。据此协议,公司向ArriVent授予独家许可,以在全球范围内(大中华地区除外)开发及商业化集团创新型抗体偶联药物(“ADC”)MRG007。

  在许可协议条款及条件的规限下,ArriVent获授权于许可地区开发、生产及商业化MRG007的独家许可。

海量资讯、精准解读,尽在新浪财经APP

责任编辑:卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10